Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Horizon Therapeutics < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > New Analyses of the MIRROR Randomized Controlled Trial in Uncontrolled Gout Presented at the 2023 EULAR European Congress of Rheumatology May 31, 2023 From Horizon Therapeutics plc Via Business Wire 3 Stocks Worth Buying at 52-Week Lows May 30, 2023 Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors Via MarketBeat FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too? May 24, 2023 Should Pfizer and Seagen investors be worried? Via The Motley Fool Horizon Therapeutics plc Announces Presentation of Data that Advances the Understanding of Rheumatic Diseases at the 2023 EULAR European Congress of Rheumatology May 23, 2023 From Horizon Therapeutics plc Via Business Wire A Look Into Horizon Therapeutics' Debt May 16, 2023 Via Benzinga Why Horizon Therapeutics Stock Is Crashing Today May 16, 2023 The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen. Via The Motley Fool Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review May 19, 2023 Chips, software and AI plays were strong. But leadership remains narrow. Via Investor's Business Daily Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny? May 19, 2023 Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal. Via MarketBeat Topics Bonds Exposures Debt Markets The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach? May 18, 2023 The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop. Via Talk Markets 10 Health Care Stocks With Whale Alerts In Today's Session May 18, 2023 Via Benzinga Horizon Therapeutics Unusual Options Activity For May 16 May 16, 2023 Via Benzinga FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal May 17, 2023 Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN) Via Benzinga Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024 May 17, 2023 Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) shares dropped sharply on Tuesday following a report suggesting the FTC is expected to file a complaint to block Amgen's Via Benzinga FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks? May 17, 2023 Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet. Via The Motley Fool Is This Dow Jones Stock a Buy for Income Investors? May 17, 2023 This pharmaceutical company is dedicated to maintaining its track record of innovation. Via The Motley Fool Why These 3 Nasdaq Stocks Buckled Today May 16, 2023 The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today. Via The Motley Fool FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A May 16, 2023 In a rare move to block a large pharma deal, the U.S. Via Benzinga Dow Down More Than 200 Points On Blue Chip Earnings May 16, 2023 Stocks are all over the place midday. Via Talk Markets Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 16, 2023 Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. Via Benzinga Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday May 16, 2023 Their declines weighed on the broader market. Via The Motley Fool Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen May 16, 2023 From Horizon Therapeutics plc Via Business Wire GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100? May 16, 2023 Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares. Via InvestorPlace Seagen (SGEN) Stock Falls 6% After Director Sells Shares May 16, 2023 Seagen (SGEN) stock is slipping on Tuesday after one of the company's directors sold shares worth more than $372,000 on Monday. Via InvestorPlace Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories May 16, 2023 Benzinga Former SVB Chief Blames Fed, Media Hype For Bank's Devastating Collapse Via Benzinga HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today May 16, 2023 Horizon Therapeutics (HZNP) stock is sinking after the FTC reportedly decided to sue to block its merger with Amgen (AMGN). Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 16, 2023 Via Benzinga Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover May 16, 2023 Reports the FTC could block Amgen's takeover of Horizon reverberated across biotechs on Tuesday, with HZNP stock's crash leading the way. Via Investor's Business Daily Why VirTra Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket May 16, 2023 Gainers VivoPower International PLC (NASDAQ: VVPR) shares surged 88.3% to $0.8701 in pre-market trading as the company reported a definitive distribution agreement to distribute EV fleet charging... Via Benzinga Amgen-Horizon Therapeutics Deal Regulatory Overhang: FTC Plans Lawsuit to Block $28B Takeover May 16, 2023 The Federal Trade Commission is expected to file a lawsuit in a bid to block Amgen Inc's (NASDAQ: AMGN) $28 billion takeover of Horizon Therapeutics PLC (NASDAQ: HZNP). Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 16, 2023 It's time to start off the day with a breakdown of all the biggest pre-market stock movers worth keeping an eye on Tuesday! Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.